The DOI matches its Crossref record; 361 of the 361 references it cites were found in a registry or an index.
Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams
Open accessAbstract
Like any other drug, antimicrobial drugs are prone to pharmacokinetic drug interactions. These drug interactions are a major concern in clinical practice as they may have an effect on efficacy and toxicity. This article provides an overview of all published pharmacokinetic studies on drug interactions of the commonly prescribed antimicrobial drugs oxazolidinones, rifamycines, macrolides, fluoroquinolones, and beta-lactams, focusing on systematic research. We describe drug-food and drug-drug interaction studies in humans, affecting antimicrobial drugs as well as concomitantly administered drugs. Since knowledge about mechanisms is of paramount importance for adequate management of drug interactions, the most plausible underlying mechanism of the drug interaction is provided when available. This overview can be used in daily practice to support the management of pharmacokinetic drug interactions of antimicrobial drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It should be noted that ciprofloxacin is metabolized in the liver and can directly inhibit CYP1A2, CYP2D6, and CYP3A4 (Bolhuis et al., 2011).”
From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Bolhuis et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–361 of 361
DeBellis, R. J., Schaefer, O. P., Liquori, M., et al. (2005) · Journal of Intensive Care Medicine · doi:10.1177/0885066605280825 · Cited by 35
Effect of Erythromycin and Itraconazole on the Pharmacokinetics of Oral Lignocaine
Isnhanni, M. H., Neuvonen, P. J., & Olkkola, K. T. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb00890.x · Cited by 35
Takagi, K., Yamaki, K., Nadai, M., et al. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1137 · Cited by 35
Effect of Cephalexin on the Pharmacokinetics of Metformin in Healthy Human Volunteers
Jayasagar, G., Kumar, M. K., Chandrasekhar, K. B., C. Madhusudan Rao, & Rao, Y. M. (2002) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2002.19.1.41 · Cited by 35
Suspected Ciprofloxacin Inhibition of Olanzapine Resulting in Increased Plasma Concentration
Markowitz, J. S., & DeVane, C. L. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00023 · Cited by 34
Clarithromycin Significantly Increases Linezolid Serum Concentrations
Bolhuis, M. S., van Altena, R., Uges, D. R. A., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00757-10 · Cited by 34
Self-citationIndinavir and Rifabutin Drug Interactions in Healthy Volunteers
Kraft, W. K., McCrea, J. B., Winchell, G. A., et al. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003262807 · Cited by 33
Parker, A., Preston, T., Heaf, D. P., Kitteringham, N. R., & Choonara, I. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04399.x · Cited by 33
Pharmacokinetic interaction between proton pump inhibitors and roxithromycin in volunteers
Kees, Holstege, Ittner, et al. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00731.x · Cited by 33
Mainz, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf172 · Cited by 33
Effect of ciprofloxacin on the pharmacokinetics of ropivacaine
Jokinen, M. J., Olkkola, K. T., Ahonen, J., et al. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0540-8 · Cited by 32
Effects of Temafloxacin and Ciprofloxacin on the Pharmacokinetics of Caffeine†
Mahr, G., Sörgel, F., Granneman, G. R., et al. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199200221-00015 · Cited by 32
The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone.
Aranko, K., Luurila, H., Backman, J. T., Neuvonen, P. J., & Olkkola, K. T. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04367.x · Cited by 32
Interaction Between Piroxicam and Azithromycin During Distribution to Human Periodontal Tissues
Malizia, T., Batoni, G., Ghelardi, E., et al. (2001) · Journal of Periodontology · doi:10.1902/jop.2000.72.9.1151 · Cited by 32
A prospective study of the clarithromycin-digoxin interaction in elderly patients
Zapater, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf176 · Cited by 32
Theophylline and Warfarin Interaction Studies with Grepafloxacin
Efthymiopoulos, C., Bramer, S. L., Maroli, A. N., et al. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199700331-00008 · Cited by 32
Staß, H., & Kubitza, D. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140001-00005 · Cited by 32
Staß, H., & Kubitza, D. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140001-00009 · Cited by 31
Mild serotonin syndrome associated with concurrent linezolid and fluoxetine
Steinberg, M., & Morin, A. K. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060227 · Cited by 31
Orlando, R., Martin, S. D., Pegoraro, P., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.216 · Cited by 31
Effect of Clarithromycin on Steady-State Digoxin Concentrations
Tanaka, H., Matsumoto, K., Ueno, K., et al. (2003) · Annals of Pharmacotherapy · doi:10.1177/106002800303700202 · Cited by 31
Tolerance and Pharmacokinetic Interactions of Rifabutin and Azithromycin
Hafner, R., Bethel, J., Standiford, H. C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1572-1577.2001 · Cited by 31
Petri, N., Borga, O., Nyberg, L., et al. (2006) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp44071 · Cited by 30
Knupp, C. A., & Barbhaiya, R. H. (1997) · Biopharmaceutics & Drug Disposition · doi:10.1002/(sici)1099-081x(199701)18:1 · Cited by 30
Comparison of dose doubling with probenecid for sustaining serum cefuroxime levels
Garton, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.6.903 · Cited by 30
Evidence of an interaction between nifedipine and nafcillin in humans
Lang, C. C., Jamal, S. K., Mohamed, Z., et al. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01789.x · Cited by 29
Paulsen, O., Nilsson, L. ‐., Saint–Salvi, B., et al. (1988) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1988.tb00943.x · Cited by 29
Drug Interactions with Clinafloxacin
Randinitis, E. J., Alvey, C. W., Koup, J. R., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2543-2552.2001 · Cited by 29
Dual Effects of Rifampin on the Pharmacokinetics of Atrasentan
Xiong, H., Carr, R. A., Locke, C. S., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299928 · Cited by 29
Serotonin Syndrome Precipitated by Linezolid in a Medically Ill Patient on Duloxetine
Strouse, T. B., Kerrihard, T. N., Forscher, C. A., & Zakowski, P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000239793.29449.75 · Cited by 29
Ciprofloxacin‐induced torsades de pointes in a methadone‐dependent patient
Nair, M. K., Patel, K., & Starer, P. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02390.x · Cited by 29
Lack of Effect of Food on the Bioavailability of a New Ketolide Antibacterial, Telithromycin
Bhargava, V. O., Lenfant, B., Perret, C., et al. (2002) · Scandinavian Journal of Infectious Diseases · doi:10.1080/0036554021000026958 · Cited by 29
Gillum, J. G., Israel, D. S., Scott, R. B., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1715 · Cited by 29
Halstenson, C. E., Hirata, C. A., HEIM-DUTHOY, K. L., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.128 · Cited by 28
Wanwimolruk, S., Kang, W., Coville, P. F., et al. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04541.x · Cited by 28
Loi, C., Parker, B., Cusack, B. J., et al. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb04216.x · Cited by 28
Lack of interaction between lomefloxacin and caffeine in normal volunteers
Healy, D. P., Schoenle, J. R., Stotka, J. L., & Polk, R. E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.4.660 · Cited by 28
Effects of rifampin on cyclosporine disposition in kidney recipients with tuberculosis
Kim, Y. H., Kim, Y. H., Yoon, Y. R., et al. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01139-7 · Cited by 28
Hypoglycemia associated with the use of levofloxacin
Garber, S. M., Pound, M. W., & Miller, S. M. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080105 · Cited by 28
Continuation of warfarin-nafcillin interaction during dicloxacillin therapy.
Taylor, A. T., Pritchard, D., Ao, G., et al. (1994) · PubMed · Cited by 28
Lahu, G., Huennemeyer, A., Herzog, R., et al. (2009) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp47236 · Cited by 28
Levofloxacin Does Not Alter Cyclosporine Disposition
Doose, D. R., Walker, S., Chien, S., Williams, R. R., & Nayak, R. K. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04382.x · Cited by 27
Changes in gastrointestinal motility influence the absorption of desmopressin
Callréus, T., Lundahl, J., Höglund, P., et al. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050633 · Cited by 27
Nakatsuka, A., Nagai, M., Yabe, H., et al. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050711 · Cited by 27
The effect of single dose of rifampicin on the pharmacokinetics of oral nifedipine
Ndanusa, B. U., Mustapha, A., & Abdu‐Aguye, I. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(97)00044-7 · Cited by 27
Pharmacokinetic Interaction between Fosamprenavir-Ritonavir and Rifabutin in Healthy Subjects
Ford, S. L., Chen, Y., Lou, Y., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00724-07 · Cited by 27
Tsutsumi, K., Kotegawa, T., Kuranari, M., Otani, Y., Morimoto, T., Matsuki, S., & Nakano, S. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002237992 · Cited by 26
Tan, K., Trull, A., & Shawket, S. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05414.x · Cited by 26
Effect of Clarithromycin and Itraconazole on the Pharmacokinetics of Ropivacaine
Jokinen, M. J., Ahonen, J., Neuvonen, P. J., et al. (2001) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2001.d01-102.x · Cited by 26
Davis, R. L., Quenzer, R. W., Kelly, H. W., et al. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202600102 · Cited by 26
Kanji, S., McKinnon, P. S., Barletta, J. F., et al. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000059317.75234.46 · Cited by 25
Interaction between Erythromycin and the Benzodiazepines Diazepam and Flunitrazepam
Luurila, H., Olkkola, K. T., & Neuvonen, P. J. (1996) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1996.tb00191.x · Cited by 25
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren
Tapaninen, T., Neuvonen, P. J., & Niemi, M. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0796-3 · Cited by 25
Pedrazzoli, S. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201317097074 · Cited by 25
Serotonin Syndrome Precipitated by the Monoamine Oxidase Inhibitor Linezolid
Packer, S., & BERMAN, S. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.346b · Cited by 25
Ciprofloxacin Bioavailability is Enhanced by Oral Co-Administration with Phenazopyridine
nez, G. M. N.-J., ngeles, A. P., nez-Rossier, L. M., et al. (2006) · Clinical Drug Investigation · doi:10.2165/00044011-200626060-00003 · Cited by 25
Amsden, G. W., Whitaker, A., & Johnson, P. W. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0095399703257218 · Cited by 24
Sekar, V. J., Spinosa‐Guzman, S., Paepe, E. D., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007309706 · Cited by 24
Winter, H. R., TRAPNELL, C., Slattery, J. T., JACOBSON, M., GREENSPAN, D., HOOTON, T., & Unadkat, J. D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.016 · Cited by 24
Lack of Pharmacokinetic Interaction between Tiagabine and Erythromycin
Thomsen, M. S., Groes, L., Agersø, H., et al. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801110 · Cited by 24
Gillum, J. G., Bruzzese, V. L., Israel, D. S., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.716 · Cited by 24
Davy, M., Allen, A., Bird, N., et al. (1999) · Chemotherapy · doi:10.1159/000007241 · Cited by 23
Maesen, F. P. V., Davies, B. I., Geraedts, W. H., et al. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.6.848 · Cited by 23
Lack of Pharmacokinetic Interaction between Gemifloxacin and Digoxin in Healthy Elderly Volunteers
Vousden, M., Allen, A., Lewis, A., et al. (1999) · Chemotherapy · doi:10.1159/000007242 · Cited by 22
Solans, A., Izquierdo, I., Donado, E., et al. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.09.002 · Cited by 22
Acute Delirium Associated with Combined Diphenhydramine and Linezolid Use
Serio, R. N. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d018 · Cited by 22
Effect of Calcium Carbonate on Bioavailability of Orally Administered Gemifloxacin
Pletz, M. W., Petzold, P., Allen, A., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2158-2160.2003 · Cited by 22
Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics
Stuht, H., Lode, H. M., Koeppe, P., et al. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.5.1045 · Cited by 22
Kim, Y.-H., Cha, I., Shim, J.-C., et al. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606000-00010 · Cited by 22
Azithromycin does not increase plasma concentrations of oral midazolam.
Backman, J. T., Olkkola, K. T., & Neuvonen, P. J. (1995) · PubMed · Cited by 22
Loi, C., Parker, B. M., Cusack, B. J., & Vestal, R. E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36457-2 · Cited by 22
Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis
Jain, A., Mehta, V. L., & Kulshrestha, S. (1993) · Tubercle and Lung Disease · doi:10.1016/0962-8479(93)90032-s · Cited by 21
The effect of food on the interaction of ofloxacin with sucralfate in healthy volunteers
Kawakami, J., Kotaki, H., SEINO, T., et al. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00193481 · Cited by 21
Damle, B. D., Kaul, S., Behr, D., et al. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002401102623 · Cited by 21
Effects of Enteral Feeding on the Oral Bioavailability of Moxifloxacin in Healthy Volunteers
Burkhardt, O., Staß, H., Thuß, U., et al. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544090-00006 · Cited by 21
Azithromycin does not alter the effects of oral midazolam on human performance
Mattila, M. J., Vanakoski, J., & Id�np��n-Heikkil�, J. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00193477 · Cited by 20
Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin
Konishi, H., Mitsuyoshi, G. O. T. O., Nakamoto, Y., et al. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.5.653 · Cited by 20
Kishore, K., Raina, A., Misra, V., et al. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700711 · Cited by 20
Effect of Calcium Supplements on the Oral Bioavailability of Moxifloxacin in Healthy Male Volunteers
Staß, H., Wandel, C., Delesen, H., et al. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140001-00004 · Cited by 19
Drug Interaction between Rifampicin and Cotrimoxazole in Patients with Tuberculosis
Bhatia, R. S., Uppal, R., Malhi, R., et al. (1991) · Human & Experimental Toxicology · doi:10.1177/096032719101000609 · Cited by 19
Gordi, T., Tan, L. H., Hong, C., et al. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257455 · Cited by 19
Effect of Chronic Probenecid Therapy on Cefazolin Serum Concentrations
Spina, S. P., & Dillon, E. C. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c347 · Cited by 19
Interaction between saquinavir soft‐gel and rifabutin in patients infected with HIV
Moyle, G. J., Buss, N., Goggin, T., et al. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01631.x · Cited by 18
Shin, K.-H., Kim, B., Kim, T., et al. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.12.012 · Cited by 18
Gallicano, K., Sahai, J. V., wick, L. S., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.4.1008 · Cited by 18
Lack of effect of erythromycin on the pharmacokinetics of single oral doses of phenytoin.
Milne, R. W., Coulthard, K. P., Nation, R. L., et al. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb05285.x · Cited by 18
Warfarin-nafcillin interaction
Davis, R. L., Berman, W., Wernly, J. A., et al. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80508-6 · Cited by 18
Possible Nafcillin-Warfarin Interaction
Heilker, G. M. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420070152023 · Cited by 18
Hassan‐Alin, M., Andersson, T., Niazi, M., et al. (2006) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp44119 · Cited by 18
Miura, M., Tada, H., Yasui‐Furukori, N., Uno, T., Sugawara, K., Tateishi, T., & Suzuki, T. (2005) · Chirality · doi:10.1002/chir.20159 · Cited by 18
Different effects of products containing metal ions on the absorption of lomefloxacin
Lehto, P., & Kivistö, K. T. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.168 · Cited by 17
Boruchoff, S. E. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.105151 · Cited by 17
la Porte, C. J. L., Sabo, J. P., Elgadi, M. M., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00534-08 · Cited by 17
Evaluation of a Potential Interaction Between Erythromycin and Glyburide in Diabetic Volunteers
Fleishaker, J. C., & Phillips, J. P. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb04972.x · Cited by 17
Benator, D., WEINER, M. H., Burman, W. J., et al. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.6.793 · Cited by 17
Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes
Shimizu, M., Uno, T., Yasui‐Furukori, N., et al. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0152-9 · Cited by 17
Serotonin Toxicity as a Consequence of Linezolid Use in Revision Hip Arthroplasty
Mason, L. W., Randhawa, K., & Carpenter, E. C. (2008) · Orthopedics · doi:10.3928/01477447-20081101-17 · Cited by 17
Quain, R. D., Barton, T. D., Fishman, N. O., et al. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.04.021 · Cited by 17
Effect of Rifampicin on the Pharmacokinetics of Atenolol
Lilja, J. J., Juntti‐Patinen, L., & Neuvonen, P. J. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_379.x · Cited by 17
Spiramycin does not potentiate quinine treatment of falciparum malaria in pregnancy
Nosten, F. H., ter Kuile, F. O., Thwai, K. L., Maelankirri, L., & White, N. J. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90139-h · Cited by 17
Lack of Pharmacokinetic Interaction between Linezolid and Antacid in Healthy Volunteers
Grunder, G., Zysset-Aschmann, Y., Vollenweider, F., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.68-72.2006 · Cited by 17
Competitive Inhibition of Renal Tubular Secretion of Gemifloxacin by Probenecid
Landersdorfer, C. B., Kirkpatrick, C. M. J., Kinzig, M., Bulitta, J. B., Holzgrabe, U., Drusano, G. L., & Sörgel, F. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01200-08 · Cited by 17
Phenytoin‐Oxacillin Interactions in Normal and Uremic Sera
Dasgupta, A., Sperelakis, A., Mason, A., et al. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03723.x · Cited by 17
Oral Cimetidine Prolongs Clarithromycin Absorption
Amsden, G. W., Cheng, K. C., Peloquin, C. A., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1578 · Cited by 17
Lack of effect of spiramycin on cyclosporin pharmacokinetics [see comments]
Vernillet, L., Bertault-Pérès, P., Berland, Y., Barradas, J., Durand, A., & Olmer, M. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03441.x · Cited by 16
Chen, Y., Cabana, B. E., Kivel, N. M., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007300745 · Cited by 16
Lack of Interaction of Erythromycin with Temazepam
Luurila, H., Olkkola, K. T., & Neuvonen, P. J. (1994) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199412000-00003 · Cited by 16
Linezolid, a Monoamine Oxidase Inhibiting Antibiotic, and Antidepressants
Aga, V. M., Barklage, N. E., & Jefferson, J. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0518b · Cited by 16
Effect of bismuth subsalicylate on ciprofloxacin bioavailability
Rambout, L., Sahai, J. V., Gallicano, K., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2187 · Cited by 16
Pharmacokinetic drug interactions of azoles
Brüggemann, R. J. M., Alffenaar, J. C., Blijlevens, N. M. A., Billaud, E. M., Kosterink, J. G. W., Verweij, P. E., & Burger, D. M. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0004-4 · Cited by 16
Self-citationInfluence of rifampin on the pharmacokinetics of pefloxacin
Humbert, G., Brumpt, I., Montay, G., et al. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.207 · Cited by 16
Wallace, A. W., Victory, J. M., & Amsden, G. W. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270002239711 · Cited by 16
Absence of a pharmacokinetic interaction between digoxin and levofloxacin
Chien, S., Rogge, M. C., Williams, R. R., Natarajan, J., Wong, F., & Chow, A. T. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00388.x · Cited by 16
Shon, J., Yeo, C., Liu, K., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009348974 · Cited by 15
Dorani, H., Schützer, K.-M., Sarich, T. C., et al. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0292-6 · Cited by 15
Probable Acenocoumarol-Amoxycillin Interaction
Soto, J., Sacristán, J. A., Alsar, M. J., et al. (2009) · Acta Haematologica · doi:10.1159/000204457 · Cited by 15
Pesco‐Koplowitz, L., Hassell, A. E., Lee, P., Zhou, H., Hall, N., Wiesinger, B. A., Mechlinski, W., Grover, M., Hunt, T., Smith, R. B., et al. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007589 · Cited by 15
Effect of ciprofloxacin on the pharmacokinetics of intravenous lidocaine
Isohanni, M. H., Ahonen, J., Neuvonen, P. J., et al. (2005) · European Journal of Anaesthesiology · doi:10.1017/s0265021505001316 · Cited by 15
Linezolid: MAOI Activity and Potential Drug Interactions
Hammerness, P. G., Parada, H. J., & Abrams, A. N. (2002) · Psychosomatics · doi:10.1176/appi.psy.43.3.248-a · Cited by 15
Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin
Washington, C. B., Hou, E., Hughes, N., et al. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050355 · Cited by 15
Rodondi, L. C., Flaherty, J. F., Schoenfeld, P. Y., et al. (1989) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1989.68 · Cited by 15
Effect of Chloroquine on the Bioavailability of Ciprofloxacin in Humans
Ilo, C., Ilondu, N. A., Okwoli, N., et al. (2006) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000178911.18614.e3 · Cited by 14
Mechanistic Study of the Azithromycin Dosage-Form-Dependent Food Effect
Curatolo, W. J., Foulds, G. H., & LaBadie, R. R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0126-6 · Cited by 14
Oral absorption of ofloxacin administered together with aluminum
Navarro, A. S., Cabarga, M. M., & Hurlé, A. D.-G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2510 · Cited by 13
Roxithromycin Does Not Raise Serum Theophylline Levels
Hashiguchi, K., Niki, Y., & Soejima, R. (1992) · CHEST Journal · doi:10.1378/chest.102.2.653 · Cited by 13
Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state
Tuominen, R. K., Männistö, P. T., Pohto, P., et al. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/21.suppl_d.45 · Cited by 13
Warfarin-flucloxacillin interaction presenting as cardioembolic ischemic stroke
Merwick, Á., Hannon, N., Kelly, P. J., et al. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0802-9 · Cited by 13
Lack of effect of fluconazole on the pharmacokinetics of rifampicin in AIDS patients
Jaruratanasirikul, S., & Kleepkaew, A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.877 · Cited by 12
A Phase I Evaluation of Concomitant Rifabutin and Didanosine in Symptomatic HIV-Infected Patients
Sahai, J. V., Narang, P. K., Hawley‐Foss, N., et al. (1995) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199507000-00008 · Cited by 12
Pharmacokinetics of dolasetron with coadministration of cimetidine or rifampin in healthy subjects
Dimmitt, D. C., Cramer, M. B., Keung, A., et al. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050872 · Cited by 12
Some Plasma and Saliva Pharmacokinetics Parameters of Rifampicin in the Presence of Pefloxacin
Orisakwe, O. E., Akunyili, D., Agbasi, P. U., et al. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000117523.18923.4a · Cited by 12
Bachmann, K. A. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00018-5 · Cited by 12
Pharmacokinetic interaction of sparfloxacin and digoxin
Johnson, R. D., Dorr, M. B., Hunt, T. L., Conway, S., & Talbot, G. H. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88293-4 · Cited by 12
Decreased INR Response Secondary to Warfarin–Flucloxacillin Interaction
Garg, A., & Mohammed, M. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l676 · Cited by 11
Influence of gatifloxacin, a new quinolone antibacterial, on pharmacokinetics of theophylline
Niki, Y., Hashiguchi, K., Miyashita, N., et al. (1999) · Journal of Infection and Chemotherapy · doi:10.1007/s101560050026 · Cited by 10
Dickens, G. R., Wermeling, D. P., & Vincent, J. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04787.x · Cited by 10
Démolis, J., Strabach, S., Vacheron, F., et al. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02395.x · Cited by 10
Rifampicin Pharmacokinetics With and Without Ciprofloxacin
Orisakwe, O. E., Agbasi, P. U., Afonne, O. J., et al. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200105000-00003 · Cited by 10
A placebo‐controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans
Magnusson, M., Bergstrand, I. C., Björkman, S. E., et al. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02549.x · Cited by 10
Interaction between Erythromycin and Nitrazepam in Healthy Volunteers
Luurila, H., Olkkola, K. T., & Neuvonen, P. J. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00139.x · Cited by 10
Pharmacokinetic interaction of diabecon (D-400) with rifampicin and nifedipine
Mitra, S. K., Sundaram, R., Venkataranganna, M. V., et al. (1999) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190014 · Cited by 10
Lack of effect of concomitant zidovudine on rifabutin kinetics in patients with AIDS-related complex
Li, R. C., Nightingale, S. D., Lewis, R. C., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1397 · Cited by 9
Effect of Chloroquine on the Urinary Excretion of Ciprofloxacin
Ilo, C. E., Ezejiofor, N. A., Agbakoba, N. R., et al. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31815db65f · Cited by 9
Effect of indinavir on the pharmacokinetics of rifampicin in HIV-infected patients
Jaruratanasirikul, S., & Sriwiriyajan, S. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775488 · Cited by 9
Ngo, L. Y., Yogev, R., Dankner, W. M., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1516 · Cited by 9
Concentrations and effects of buspirone are considerably reduced by rifampicin
Lamberg, Kivisto, & Neuvonen (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00698.x · Cited by 9
Kirch, W., Milferstädt, S., Halabi, A., et al. (1990) · Cardiovascular Drugs and Therapy · doi:10.1007/bf01857758 · Cited by 8
Capone, D., Tarantino, G., Polichetti, G., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347869 · Cited by 8
Effect of Clarithromycin on the Pharmacokinetics of Tolbutamide
Jayasagar, G., A.A. Dixit, V. Kishan, et al. (2000) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2000.16.3.207 · Cited by 8
Effect of Clarithromycin and Itraconazole on the Pharmacokinetics of Ropivacaine
Jokinen, M. J., Ahonen, J., Neuvonen, P. J., et al. (2001) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.2001.880405.x · Cited by 8
The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn, H. C., & Lee, Y.-C. (2003) · PubMed · Cited by 7
Hypotension Associated With Intravenous Haloperidol and Imipenem
Franco-Bronson, K., & Gajwani, P. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00019 · Cited by 7
Effects of Rifampin on Cyclosporine Disposition in Kidney Recipients with Tuberculosis
Shon, J., Yoon, Y., Kim, K., et al. (2000) · Journal of Korean Society for Clinical Pharmacology and Therapeutics · doi:10.12793/jkscpt.2000.8.1.91 · Cited by 7
Li, R. C., Narang, P. K., Sahai, J. V., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1566 · Cited by 6
Evaluation of Promotility Agents to Limit the Gut Bioavailability of Extended Release Acetaminophen
Amato, C. S., Wang, R. Y., Wright, R. O., et al. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120028748 · Cited by 5
Ortiz, R. A., Calafatti, S. A., Moraes, L. A., et al. (2007) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2007000300014 · Cited by 5
Serotonin syndrome after single doses of co-amoxiclav during treatment with venlafaxine
Connor, H. (2003) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.96.5.233 · Cited by 5
Bartolucci, L., Gradoli, C., Vincenzi, V., et al. (1984) · PubMed · Cited by 5
Serotonin Syndrome after Single Doses of Co-Amoxiclav during Treatment with Venlafaxine
Connor, H. (2003) · Journal of the Royal Society of Medicine · doi:10.1177/014107680309600508 · Cited by 5
Amsden, G. W., Flaherty, J. F., & Luke, D. R. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122009908 · Cited by 3
Lack of effect of rifalazil on ethinyl estradiol pharmacokinetics in healthy postmenopausal women
Chen, Y., Cabana, B. E., Kivel, N. M., et al. (2007) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp45418 · Cited by 3
Flagged first, then by citations
Research works printed but not linked: 1
- Stockley, I. (2011). Stockley's Drug Interactions, Pharmaceutical Press. [6th ed.].
Cited by
Sorted by citations
Gut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319
Metadata
- Authors
- Bolhuis, M. S., Panday, P. N., Pranger, A. D., Kosterink, J. G. W., & Alffenaar, J.-W. C.
- Affiliations
- University Medical Center Groningen (NL)
- Department of Hospital and Clinical Pharmacy, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands
- Corresponding author
- Bolhuis, Mathieu S.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2011-11-18
- Volume
- 3
- Issue
- 4
- Pages
- 865-913
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC3857062
- OpenAlex
- W2151599229
- Cited by
- 62
- References
- 361
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 8 · 2023: 5 · 2022: 9 · 2021: 4 · 2020: 12 · 2019: 6 · 2018: 2 · 2017: 5 · 2015: 2 · 2014: 3
- FWCI
- 0.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- pharmacokinetic interactions, antimicrobial agents, oxazolidinones, macrolides, fluoroquinolones, beta-lactam antibiotics, food-drug interactions, drug-drug interactions, interaction mechanisms, drug efficacy and toxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review